Rediscovering Psilocybin as an Antidepressive Treatment Strategy
There has recently been a renewal of interest in psychedelic research on the use of psilocybin in psychiatric treatment and, in particular, for the treatment of major depressive disorder (MDD). Several state-of-the-art studies have provided new insight into the mechanisms of action of psilocybin and...
| Published in: | Pharmaceuticals |
|---|---|
| Main Authors: | Rene Zeiss, Maximilian Gahr, Heiko Graf |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-09-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/14/10/985 |
Similar Items
Psilocybin for Treating Psychiatric Disorders: A Psychonaut Legend or a Promising Therapeutic Perspective?
by: Maurizio Coppola, et al.
Published: (2022-02-01)
by: Maurizio Coppola, et al.
Published: (2022-02-01)
Mushrooms, Microdosing, and Mental Illness: The Effect of Psilocybin on Neurotransmitters, Neuroinflammation, and Neuroplasticity
by: Kinderlehrer DA
Published: (2025-01-01)
by: Kinderlehrer DA
Published: (2025-01-01)
In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin
by: Nathan T. Jones, et al.
Published: (2024-01-01)
by: Nathan T. Jones, et al.
Published: (2024-01-01)
Development of a PBPK model of psilocybin/psilocin from Psilocybe cubensis (magic mushroom) in mice, rats, and humans
by: Nilubon Thaoboonruang, et al.
Published: (2025-04-01)
by: Nilubon Thaoboonruang, et al.
Published: (2025-04-01)
Neurobiology of psilocybin: a comprehensive overview and comparative analysis of experimental models
by: Dotun Adeyinka, et al.
Published: (2025-08-01)
by: Dotun Adeyinka, et al.
Published: (2025-08-01)
Psilocybin Use in an Intercollegiate Athlete with Persisting Symptoms After Concussion: A Case Report
by: David W. Lawrence, et al.
Published: (2025-07-01)
by: David W. Lawrence, et al.
Published: (2025-07-01)
Effects of Psilocin and Psilocybin on Human 5-HT<sub>4</sub> Serotonin and H<sub>2</sub> Histamine Receptors in Perfused Hearts of Transgenic Mice
by: Pauline Braekow, et al.
Published: (2025-07-01)
by: Pauline Braekow, et al.
Published: (2025-07-01)
Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy: a case report
by: André Do, et al.
Published: (2024-07-01)
by: André Do, et al.
Published: (2024-07-01)
Effects of hallucinogenic drugs on the human heart
by: Joachim Neumann, et al.
Published: (2024-02-01)
by: Joachim Neumann, et al.
Published: (2024-02-01)
Psychotherapy with Psilocybin for Depression: Systematic Review
by: Jonathan Joseph Dawood Hristova, et al.
Published: (2023-03-01)
by: Jonathan Joseph Dawood Hristova, et al.
Published: (2023-03-01)
Psilocybin as a new way for depression treatment
by: Mateusz Maciej Pawlicki, et al.
Published: (2024-05-01)
by: Mateusz Maciej Pawlicki, et al.
Published: (2024-05-01)
Therapeutic and legal aspects of psilocybin in cancer-related depression
by: Małgorzata Wierzbicka, et al.
Published: (2025-08-01)
by: Małgorzata Wierzbicka, et al.
Published: (2025-08-01)
Correction: Therapeutic and legal aspects of psilocybin in cancer-related depression
by: Małgorzata Wierzbicka, et al.
Published: (2025-09-01)
by: Małgorzata Wierzbicka, et al.
Published: (2025-09-01)
Chemical Composition and Biological Activities of <i>Psilocybe</i> Mushrooms: Gaps and Perspectives
by: Mateus A. Luz, et al.
Published: (2025-07-01)
by: Mateus A. Luz, et al.
Published: (2025-07-01)
Exploring <i>Psilocybe cubensis</i> Strains: Cultivation Techniques, Psychoactive Compounds, Genetics and Research Gaps
by: Eyal Kurzbaum, et al.
Published: (2025-01-01)
by: Eyal Kurzbaum, et al.
Published: (2025-01-01)
Effects of psilocybin-assisted therapy on treatment-resistant depression
by: A. Fraga, et al.
Published: (2021-04-01)
by: A. Fraga, et al.
Published: (2021-04-01)
Psilocybin's Emerging Role in Combating Depressive Disorder
by: Anna Jaremek, et al.
Published: (2023-08-01)
by: Anna Jaremek, et al.
Published: (2023-08-01)
Association of Psilocybin Use in Adolescents with Major Depressive Episode
by: K. Shah, et al.
Published: (2022-06-01)
by: K. Shah, et al.
Published: (2022-06-01)
A Review of Synthetic Access to Therapeutic Compounds Extracted from <i>Psilocybe</i>
by: Raphaël Serreau, et al.
Published: (2022-12-01)
by: Raphaël Serreau, et al.
Published: (2022-12-01)
Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials
by: Shuping Fang, et al.
Published: (2024-02-01)
by: Shuping Fang, et al.
Published: (2024-02-01)
Risks of using psilocybin in treatment of treatment-resistant depression
by: Michał Orzechowski, et al.
Published: (2025-03-01)
by: Michał Orzechowski, et al.
Published: (2025-03-01)
Exploring the role of the psychedelic alkaloid psilocybin in alleviating cancer-related distress
by: Fejzić Dino
Published: (2025-03-01)
by: Fejzić Dino
Published: (2025-03-01)
Psilocybin and Mental Health–Don't Lose Control
by: Joseph M. Barnby, et al.
Published: (2018-07-01)
by: Joseph M. Barnby, et al.
Published: (2018-07-01)
Sexual Dysfunction Induced by Antidepressants—A Pharmacovigilance Study Using Data from VigiBase<sup>TM</sup>
by: Rene Zeiss, et al.
Published: (2024-06-01)
by: Rene Zeiss, et al.
Published: (2024-06-01)
The association between diverse psychological protocols and the efficacy of psilocybin-assisted therapy for clinical depressive symptoms: a Bayesian meta-analysis
by: Mu-Hong Chen, et al.
Published: (2024-08-01)
by: Mu-Hong Chen, et al.
Published: (2024-08-01)
The Promise of Therapeutic Psilocybin: An Evaluation of the 134 Clinical Trials, 54 Potential Indications, and 0 Marketing Approvals on ClinicalTrials.gov
by: Norring SA, et al.
Published: (2024-04-01)
by: Norring SA, et al.
Published: (2024-04-01)
Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: an open-label pilot clinical trial
by: Jacob S. Aday, et al.
Published: (2025-03-01)
by: Jacob S. Aday, et al.
Published: (2025-03-01)
Optimization through a Box–Behnken Experimental Design of the Microwave-Assisted Extraction of the Psychoactive Compounds in Hallucinogenic Fungi (<i>Psylocibe cubensis</i>)
by: Curro Polo-Castellano, et al.
Published: (2022-06-01)
by: Curro Polo-Castellano, et al.
Published: (2022-06-01)
Psilocybin for major depressive disorder: a systematic review of randomized controlled studies
by: Li-Juan Li, et al.
Published: (2024-09-01)
by: Li-Juan Li, et al.
Published: (2024-09-01)
L’effet bénéfique de l’expérience mystique dans le trouble dépressif caractérisé à travers l’utilisation de la psilocybine
by: Alessia Calanchini
Published: (2024-09-01)
by: Alessia Calanchini
Published: (2024-09-01)
Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder
by: Sandra Szafoni, et al.
Published: (2024-06-01)
by: Sandra Szafoni, et al.
Published: (2024-06-01)
Evidence versus expectancy: the development of psilocybin therapy
by: James J. Rucker
by: James J. Rucker
Psilocybin - new remedy for patients with psychiatric disorders? Critical analysis of the current state of knowledge
by: Karolina Wąsik, et al.
Published: (2023-12-01)
by: Karolina Wąsik, et al.
Published: (2023-12-01)
Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: A Systematic Review
by: Gniewko Więckiewicz, et al.
Published: (2021-08-01)
by: Gniewko Więckiewicz, et al.
Published: (2021-08-01)
The Emergence of Psilocybin in Psychiatry and Neuroscience
by: Hossein Omidian, et al.
Published: (2025-04-01)
by: Hossein Omidian, et al.
Published: (2025-04-01)
Psilocybin for Depression: From Credibility to Feasibility, What’s Missing?
by: Antonio Munafò, et al.
Published: (2022-12-01)
by: Antonio Munafò, et al.
Published: (2022-12-01)
Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases—A Systematic Review and Meta-Analysis of Clinical Trials
by: Ana Sofia Vargas, et al.
Published: (2020-09-01)
by: Ana Sofia Vargas, et al.
Published: (2020-09-01)
Christian Responses to Psilocybin-Assisted Therapy and Potential Religious and Spiritual Experiences
by: Brian Claude Macallan
Published: (2023-10-01)
by: Brian Claude Macallan
Published: (2023-10-01)
Underlying pharmacological mechanisms of psilocin-induced broadband desynchronization and disconnection of EEG in rats
by: Filip Tylš, et al.
Published: (2023-06-01)
by: Filip Tylš, et al.
Published: (2023-06-01)
Electrical spiking of psilocybin fungi
by: Antoni Gandia, et al.
Published: (2022-12-01)
by: Antoni Gandia, et al.
Published: (2022-12-01)
Similar Items
-
Psilocybin for Treating Psychiatric Disorders: A Psychonaut Legend or a Promising Therapeutic Perspective?
by: Maurizio Coppola, et al.
Published: (2022-02-01) -
Mushrooms, Microdosing, and Mental Illness: The Effect of Psilocybin on Neurotransmitters, Neuroinflammation, and Neuroplasticity
by: Kinderlehrer DA
Published: (2025-01-01) -
In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin
by: Nathan T. Jones, et al.
Published: (2024-01-01) -
Development of a PBPK model of psilocybin/psilocin from Psilocybe cubensis (magic mushroom) in mice, rats, and humans
by: Nilubon Thaoboonruang, et al.
Published: (2025-04-01) -
Neurobiology of psilocybin: a comprehensive overview and comparative analysis of experimental models
by: Dotun Adeyinka, et al.
Published: (2025-08-01)
